Previous Article | Next Article 
Infection and Immunity, October 1998, p. 4947-4949, Vol. 66, No. 10
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Production of Interleukin-12 by Murine Macrophages
in Response to Bacterial Peptidoglycan
Christine
Lawrence, and
Charles
Nauciel*
Laboratoire de Microbiologie, Faculté
de Médecine de Paris-Ouest, 92380 Garches, France
Received 19 March 1998/Returned for modification 24 April
1998/Accepted 21 July 1998
 |
ABSTRACT |
Peptidoglycan (PG), a component of the bacterial cell wall, has
various immunomodulating activities, including the capacity to induce
delayed-type hypersensitivity reactions to antigens administered in
Freund's adjuvant. We report that PG induces interleukin-12 (IL-12)
mRNA production and IL-12 secretion by mouse macrophages. The capacity
of PG to induce IL-12 production, like its previously reported
immunomodulating activities, was dependent on the structure of its
peptide subunit. PG from Bacillus megaterium and
Staphylococcus aureus induced IL-12 production, whereas PG
from Micrococcus luteus and Corynebacterium
poinsettiae did not. The ability of most bacterial PGs to induce
IL-12 production suggests that they play an important role in
triggering host defense mechanisms against bacterial infections.
 |
INTRODUCTION |
Peptidoglycan (PG) is a polymer
present in the cell wall of almost all bacterial species. It is
composed of glycan chains cross-linked by short peptides. PG is
responsible for cell wall rigidity. PG possesses various
immunomodulating activities (9) and therefore probably plays
an important role in triggering host responses to bacterial infections.
The monomeric subunit of PG, usually a disaccharide-tetrapeptide, also
possesses immunoadjuvant properties (21); the smallest structure with these activities is
N-acetyl-muramyl-L-alanyl-D-isoglutamine (muramyl-dipeptide) (1). The structure of the peptide
portion of PG can vary among gram-positive species (25).
Some PGs, such as those of Micrococcus luteus and
Corynebacterium poinsettiae, are devoid of immunomodulating
properties (10, 11, 15).
The mechanism of action of PG has been the subject of many studies. PG
is a mitogen (6, 11) and a polyclonal activator (8) of B cells and induces macrophages to secrete various
cytokines, including interleukin-1 (IL-1), IL-6, and tumor necrosis
factor alpha (13, 27, 31, 32). Although much less toxic, PG
shares many properties with bacterial lipopolysaccharide (LPS). Both molecules are known to interact with the macrophage receptor CD14 (12). One of the most striking properties of PG is its
ability to substitute for mycobacteria in complete Freund's adjuvant
and to induce a delayed-type hypersensitivity reaction to antigens present in the water-in-oil emulsion (22). Delayed-type
hypersensitivity is classified as a typical Th1 response
(19), and IL-12 has been shown to be of critical importance
for the induction of this type of response (14, 16, 28).
The aim of this study was to determine the capacity of PGs with various
structures to induce IL-12 production by macrophages.
 |
MATERIALS AND METHODS |
PGs.
The bacterial species used were Bacillus
megaterium ATCC 14581, Staphylococcus aureus
Copenhagen, M. luteus A270 (Institut Pasteur), and C. poinsettiae NCPP 846. PGs were purified as previously described
(11). Briefly, bacteria were disrupted by sonication, and
cell walls were collected by differential centrifugation and digested
with trypsin (0.5 mg/ml) and RNase (5 µg/ml) in 0.05 M phosphate
buffer (pH 7.8) at 37°C for 16 h. The residue was treated with
1% sodium dodecyl sulfate in a boiling water bath for 10 min and then
centrifuged. The pellet was washed thoroughly with distilled water.
Teichoic acid was extracted with 10% trichloroacetic acid at 4°C for
3 days. The insoluble residue was washed three times in distilled water
and lyophilized.
The chemical composition of the peptide moiety of each preparation was
checked by amino acid analysis. The expected ratio of amino acids
present in the various PGs was found, and only traces of other amino
acids were detected. Before use, PGs were resuspended by brief
sonication in Hanks' balanced salt solution and placed for 3 min in a
boiling water bath. All PG preparations were tested for LPS
contamination in the Limulus amoebocyte lysate assay
(Kinetic-QCL; Bio-Whittaker, Emerainville, France). In all preparations, LPS activity was less than 2 endotoxin units per mg of
PG.
PG lysozyme digestion.
A sample of PG from B. megaterium (1 mg/ml) was treated for 3 min in a boiling water bath
and incubated overnight at 37°C, in sterile conditions, with 40 µg
of egg white lysozyme (Sigma Chemical Co., L'Isle d'Abeau Chesnes,
France) per ml in 0.15 M phosphate buffer (pH 6.2).
Macrophages.
The mouse macrophage cell line J774 was
cultured in RPMI 1640 medium supplemented with 10% heat-inactivated
fetal calf serum, 2 mM glutamine, 50 µg of gentamicin per ml, and 100 U of penicillin per ml. A cell suspension (5 × 105 in
1.5 ml) was plated on 40-mm-diameter tissue culture dishes and allowed
to adhere for 2 h.
The macrophage monolayers were then treated with various concentrations
of LPS (LPS from Salmonella typhimurium; Difco Laboratories, Detroit, Mich.) and PGs and incubated for 24 h at 37°C with 5% CO2. Culture supernatants were harvested for IL-12 assay.
Cells were harvested at various times for RNA extraction.
RT-PCR.
Total RNA was isolated from macrophages by a
single-step method with the Extract-all reagent (Eurobio, Les Ulis,
France) as recommended by the manufacturer, and cDNA was synthesized in
a volume of 20 µl as follows. Ten microliters of RNA preparation was
mixed with 1 µl of oligo(dT) (Pharmacia, Uppsala, Sweden) and heated
for 5 min at 70°C. A mixture of 4 µl of reverse transcriptase (RT)
buffer, 2 µl of 0.1 M dithiothreitol, 1 µl of Superscript RNase
H
RT (Life Technologies, Cergy-Pontoise, France), 50 µM
deoxynucleoside triphosphates (Pharmacia), and 1 µl of RNAguard
(Pharmacia) was added; the mixture was incubated for 90 min at 38°C
and heated for 5 min at 95°C.
PCR amplifications were performed in a total volume of 50 µl. The PCR
mixture consisted of 3.5 µl of PCR buffer (100 mM Tris-HCl [pH 9],
15 mM MgCl2, 500 mM KCl, 1% Triton X-100, 0.1% gelatin), 50 µmol of each deoxynucleoside triphosphate, 2.5 µl of glycerol, and 2.5 U of Taq DNA polymerase (ATGC, Noisy le Grand,
France) per reaction. Five microliters of 10-fold-diluted cDNA and 10 pmol of each primer were then added. The following oligonucleotides were used as described previously (23): for
-actin,
5'-GATCCACATCTGCTGGAAGGT-3' and
5'-GGTGACGAGGCCCAGAGCAAG-3' (nucleotides 242 to 1151); for IL-12 p40, 5'-GACCCTGCCCATTGAACTGGC-3' and
5'-CAACGTTGCATCCTAGGATCG-3' (nucleotides 639 to 1034). The
reaction mixtures were overlaid with 100 µl of paraffin oil and
incubated for 5 min at 95°C. A total of 29 cycles for
-actin and
33 cycles for IL-12 p40 (95°C for 1 min, 55°C for 1 min, and 72°C
for 1 min, with an additional final step of 10 min) were run in a
Crocodile II thermal cycler (Appligene, Pleasanton, Calif.). PCR
products were then separated in 1.5% agarose gel by electrophoresis
and visualized by ethidium bromide staining.
IL-12 assay.
IL-12 was quantified in culture supernatants by
using a sandwich enzyme-linked immunosorbent assay (ELISA) (Genzyme,
Cambridge, Mass.) according to the manufacturer's instructions. This
assay is specific for both free and heterodimer-associated p40 chains, and its detection limit is 10 pg/ml.
 |
RESULTS |
Induction of IL-12 mRNA by PG.
PG from B. megaterium induced the production of IL-12 mRNA by J774 cells.
IL-12 mRNA was detected as early as 3 h after the addition of PG
(Fig. 1). Only a weak signal was obtained
with 1 µg/ml, and the signal intensity increased with the PG
concentration. No signal was detected in the negative control
(unstimulated J774 cells), whereas IL-12 mRNA was strongly induced by
LPS.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 1.
Induction by B. megaterium PG of IL-12 p40
mRNA in the J774 macrophage cell line. Macrophages were incubated with
the indicated concentrations (micrograms per milliliter) of LPS or PG
from B. megaterium. Unstimulated macrophages were used as a
control. Total RNA was extracted at the indicated times, reverse
transcribed, and amplified by PCR with primers specific for IL-12 p40
and -actin. Amplified products were submitted to agarose gel
electrophoresis and stained with ethidium bromide. M, molecular size
markers.
|
|
Correlation between PG peptide subunit structure and IL-12 mRNA
induction.
The peptides subunit of the PGs used to stimulate J774
cells are shown in Table 1. The PGs from
B. megaterium and S. aureus, which are known to
possess immunomodulating activities, induced IL-12 mRNA synthesis (Fig.
2), whereas PGs from M. luteus
and C. poinsettiae, which are devoid of immunomodulating
activities, did not.

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 2.
Correlation between PG structure and the ability to
induce IL-12 p40 mRNA. Macrophages were incubated for 24 h with
the indicated concentrations of LPS or with PG from B. megaterium (B. meg.), S. aureus (S. aur.), C. poinsettiae (C. poin.), and
M. luteus (M. lut.). IL-12 p40 and -actin
mRNAs were amplified as described in the legend to Fig. 1. Results are
representative of three experiments. M, molecular size markers.
|
|
Lysozyme digestion of PG from B. megaterium strongly reduced
its activity, showing that its polymeric structure is necessary to
induce IL-12 mRNA (Fig. 3).

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 3.
Effect of lysozyme digestion on the capacity of PG from
B. megaterium to induce IL-12 mRNA production in J774 cells.
RT-PCR was carried out after 24 h of incubation. Lanes: 1, control; 2, LPS (10 µg/ml); 3, PG from B. megaterium (100 µg/ml); 4, PG from B. megaterium (100 µg/ml after
lysozyme digestion). M, molecular size markers.
|
|
Induction of IL-12 secretion by PG.
To determine whether IL-12
was secreted by J774 cells, culture supernatants were harvested after
24 h of exposure to PG, and IL-12 was quantified by ELISA. PGs
from B. megaterium and S. aureus, which induce
IL-12 mRNA, also induced IL-12 secretion. PGs from C. poinsettiae and M. luteus were inactive. PG from
B. megaterium had no activity after lysozyme digestion
(Table 2).
 |
DISCUSSION |
IL-12 is a heterodimeric cytokine produced in response to
infection by various pathogens (3, 5, 23). In vitro, both live and killed bacteria induce IL-12 production by macrophages (4, 5, 7, 14, 17, 26). Among the bacterial components able
to induce IL-12 production, LPS, present in gram-negative bacteria, is
highly effective (7, 26). Heat shock proteins and
double-stranded RNA have also been reported to induce IL-12 synthesis
(26).
We found that PG also triggered IL-12 production. PG activity was not
related to LPS contamination. To minimize the risk of LPS
contamination, PGs were extracted from gram-positive species. Only
traces of LPS activity were found in the PG preparations with the
Limulus amoebocyte lysate assay. Moreover, the capacity to
induce IL-12 secretion was lost after lysozyme treatment, showing that
the biological activity depended on the polymeric structure of PG and
not on LPS contamination. The capacity of PG to induce the production
of other cytokines is also reduced by lysozyme treatment (27,
31).
In most PGs, the first two amino acids of the peptide subunit are
L-Ala-D-Glu. These PGs were previously found to
exhibit immunomodulating activities (10, 11, 31, 32), and
here we show that they induce IL-12 production. The PGs from M. luteus and C. poinsettiae, which are devoid of
immunomodulating activities (10, 11, 15, 31, 32), failed to
induce IL-12 production. The peptide subunit sequences of these PGs
exhibit unusual features. In M. luteus, the
-carboxyl
group of the glutaminyl residue is linked to a glycyl residue. In
C. poinsettiae PG, the first amino acid is glycine instead
of L-alanine. Moreover, the
-carboxyl group of the
glutaminyl residue is involved in interpeptide bridge formation. The
key role of the first two amino acids of the peptide subunit has been
confirmed in studies of synthetic PG derivatives (1).
IL-12 is a key cytokine in the host response to bacterial infection
(2). Macrophage IL-12 production is necessary to induce natural killer cells to synthesize gamma interferon (28,
29), which plays a major role in innate resistance to infection,
by activating macrophage bactericidal functions.
IL-12 also plays an important role in the regulation of adaptive immune
responses, by favoring the differentiation of CD4+ T cells
toward the Th1 pathway (28). IL-12 participates in the
induction of delayed-type hypersensitivity (16) and contact sensitivity (20), both of which are mediated by Th1 cells.
Th1 cells are also involved in resistance to intracellular pathogens by
the production of gamma interferon. The role of IL-12 in resistance to
various bacterial infections is shown by the detrimental effect of
anti-IL-12 monoclonal antibody administration (3, 5, 18, 24, 30,
33). By inducing IL-12 production, PG both triggers innate
immunity and regulates adaptive immunity. It is thus likely that PG
plays a major role in triggering host responses to bacteria, especially
gram-positive species, which lack LPS.
 |
ACKNOWLEDGMENT |
We thank Delphine Verjat (Pharmacie Centrale des Hôpitaux,
Assistance Publique de Paris) for performing the Limulus
amoebocyte lysate assay.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Laboratoire de
Microbiologie, Faculté de Médecine Paris-Ouest, 104 bd R. Poincaré, 92380 Garches, France. Phone: 33-1 47 10 79 50. Fax:
33-1 47 10 79 49. E-mail: charles.nauciel{at}rpc.ap-hop-paris.fr.
Editor:
S. H. E. Kaufmann
 |
REFERENCES |
| 1.
|
Adam, A.,
J.-F. Petit,
P. Lefrancier, and E. Lederer.
1981.
Muramyl peptides. Chemical structure, biological activity and mechanism of action.
Mol. Cell. Biochem.
41:27-47[Medline].
|
| 2.
|
Biron, C. A., and R. T. Gazzinelli.
1995.
Effects of IL-12 on immune responses to microbial infections: a key mediator in regulating disease outcome.
Curr. Opin. Immunol.
7:485-496[Medline].
|
| 3.
|
Bohn, E., and I. B. Autenrieth.
1996.
IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN- production in NK cells and CD4+ T cells.
J. Immunol.
156:1458-1468[Abstract].
|
| 4.
|
Chong, C.,
K. L. Bost, and J. D. Clemets.
1996.
Differential production of interleukin-12 mRNA by murine macrophages in response to viable or killed Salmonella spp.
Infect. Immun.
64:1154-1160[Abstract].
|
| 5.
|
Cooper, A. M.,
A. D. Roberts,
E. R. Rhoades,
J. E. Callahan,
D. M. Getzy, and I. M. Orme.
1995.
The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection.
Immunology
84:423-432[Medline].
|
| 6.
|
Damais, C.,
C. Bona,
L. Chedid,
J. Fleck,
C. Nauciel, and J. P. Martin.
1975.
Mitogenic effect of bacterial peptidoglycans possessing adjuvant activity.
J. Immunol.
115:268-271[Abstract/Free Full Text].
|
| 7.
|
D'Andrea, A.,
M. Rengaraju,
N. M. Valiante,
J. Chehimi,
M. Kubin,
M. Aste,
S. H. Chan,
M. Kobayashi,
D. Young,
E. Nickbarg,
R. Chizzonite,
S. F. Wolf, and G. Trinchieri.
1992.
Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells.
J. Exp. Med.
176:1387-1398[Abstract/Free Full Text].
|
| 8.
|
Dziarski, R.
1980.
Polyclonal activation of immunoglobulin secretion in B lymphocytes induced by staphylococcal peptidoglycan.
J. Immunol.
125:2478-2483[Abstract].
|
| 9.
|
Dziarski, R.
1986.
Effects of peptidoglycan on the cellular components of the immune system, p. 229-247.
In
P. H. Seidl, and K. H. Schleifer (ed.), Biological properties of peptidoglycan. Walter de Gruyter, Berlin, Germany.
|
| 10.
|
Goguel, A.-F.,
G. Lespinats, and C. Nauciel.
1982.
Peptidoglycans extracted from gram-positive bacteria: expression of antitumor activity according to peptide structure and route of injection.
J. Natl. Cancer Inst.
68:657-663.
|
| 11.
|
Guenounou, M.,
A.-F. Goguel, and C. Nauciel.
1982.
Study of adjuvant and mitogenic activities of bacterial peptidoglycans with different structures.
Ann. Immunol. (Paris)
133D:3-13.
|
| 12.
|
Gupta, D.,
T. N. Kirkland,
S. Viriyakosol, and R. Dziarski.
1996.
CD14 is a cell-activating receptor for bacterial peptidoglycan.
J. Biol. Chem.
271:23310-23316[Abstract/Free Full Text].
|
| 13.
|
Heumann, D.,
C. Barras,
A. Severin,
M. P. Glauser, and A. Tomasz.
1994.
Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes.
Infect. Immun.
62:2715-2721[Abstract/Free Full Text].
|
| 14.
|
Hsieh, C.-S.,
S. E. Macatonia,
C. S. Tripp,
S. F. Wolf,
A. O'Garra, and K. M. Murphy.
1993.
Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.
Science
260:547-549[Abstract/Free Full Text].
|
| 15.
|
Kotani, S.,
Y. Watanabe,
F. Kinoshita,
K. Kato,
K. H. Schleifer, and H. R. Perkins.
1977.
Inabilities as an immunoadjuvant of cell walls of the group B peptidoglycan types and those of arthrobacters.
Biken J.
20:1-4[Medline].
|
| 16.
|
Magram, J.,
S. E. Connaughton,
R. R. Warrier,
D. M. Carvajal,
C.-Y. Wu,
J. Ferrante,
C. Stewart,
U. Sarmiento,
D. A. Faherty, and M. K. Gately.
1996.
IL-12-deficient mice are defective in IFN- production and type 1 cytokine responses.
Immunity
4:471-481[Medline].
|
| 17.
|
Mahon, B. P.,
M. S. Ryan,
F. Griffin, and K. H. G. Mills.
1996.
Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells.
Infect. Immun.
64:5295-5301[Abstract].
|
| 18.
|
Mastroeni, P.,
J. A. Harrison,
J. A. Chabalgoity, and C. E. Hormaeche.
1996.
Effect of interleukin 12 neutralization on host resistance and gamma interferon production in mouse typhoid.
Infect. Immun.
64:189-196[Abstract].
|
| 19.
|
Mosmann, T. R., and R. L. Coffman.
1989.
Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties.
Ann. Rev. Immunol.
7:145-173[Medline].
|
| 20.
|
Müller, G.,
J. Saloga,
T. Germann,
G. Schuler,
J. Knop, and A. H. Enk.
1995.
IL-12 as mediator and adjuvant for the induction of contact sensitivity in vivo.
J. Immunol.
155:4661-4668[Abstract].
|
| 21.
|
Nauciel, C.,
J. Fleck,
M. Mock, and J. P. Martin.
1973.
Activité adjuvante de fractions monomériques de peptidoglycanes bactériens dans l'hypersensibilité de type retardé.
C. R. Acad. Sci. Ser. D
277:2841-2844.
|
| 22.
|
Nauciel, C.,
J. Fleck,
J. P. Martin,
M. Mock, and H. Nguyen-Huy.
1974.
Adjuvant activity of bacterial peptidoglycans on the production of delayed hypersensitivity and on antibody response.
Eur. J. Immunol.
4:352-356[Medline].
|
| 23.
|
Pie, S.,
P. Truffa-Bachi,
M. Pla, and C. Nauciel.
1997.
Th1 response in Salmonella typhimurium-infected mice with a high or low rate of bacterial clearance.
Infect. Immun.
65:4509-4514[Abstract].
|
| 24.
|
Saunders, B. M.,
Y. Zhan, and C. Cheers.
1995.
Endogenous interleukin-12 is involved in resistance of mice to Mycobacterium avium complex infection.
Infect. Immun.
63:4011-4015[Abstract].
|
| 25.
|
Schleifer, K. H., and O. Kandler.
1972.
Peptidoglycan types of bacterial cell walls and their taxonomic implications.
Bacteriol. Rev.
36:407-477[Free Full Text].
|
| 26.
|
Skeen, M. J.,
M. A. Miller,
T. M. Shinnick, and H. K. Ziegler.
1996.
Regulation of murine macrophage IL-12 production. Activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines.
J. Immunol.
156:1196-1206[Abstract].
|
| 27.
|
Timmerman, C. P.,
E. Mattsson,
L. Martinez-Martinez,
L. de Graaf,
J. A. G. van Strijp,
H. A. Verbrugh,
J. Verhoef, and A. Fleer.
1993.
Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans.
Infect. Immun.
61:4167-4172[Abstract/Free Full Text].
|
| 28.
|
Trinchieri, G.
1995.
Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity.
Annu. Rev. Immunol.
13:251-276[Medline].
|
| 29.
|
Tripp, C. S.,
S. F. Wolf, and E. R. Unanue.
1993.
Interleukin 12 and tumor necrosis factor are costimulators of interferon production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist.
Proc. Natl. Acad. Sci. USA
90:3725-3729[Abstract/Free Full Text].
|
| 30.
|
Tripp, C. S.,
M. K. Gately,
J. Hakimi,
P. Ling, and E. R. Unanue.
1994.
Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. Reversal by IFN- .
J. Immunol.
152:1883-1887[Abstract].
|
| 31.
|
Vacheron, F.,
M. Guenounou, and C. Nauciel.
1983.
Induction of interleukin 1 secretion by adjuvant-active peptidoglycans.
Infect. Immun.
42:1049-1054[Abstract/Free Full Text].
|
| 32.
|
Vacheron, F.,
M. Guenounou,
H. Zinbi, and C. Nauciel.
1986.
Release of a cytotoxic factor by macrophages stimulated with adjuvant-active peptidoglycans.
J. Natl. Cancer Inst.
77:549-553.
|
| 33.
|
Zhan, Y., and C. Cheers.
1995.
Endogenous interleukin-12 is involved in resistance to Brucella abortus infection.
Infect. Immun.
63:1387-1390[Abstract].
|
Infection and Immunity, October 1998, p. 4947-4949, Vol. 66, No. 10
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Visser, L., Melief, M.-J., van Riel, D., van Meurs, M., Sick, E. A., Inamura, S., Bajramovic, J. J., Amor, S., Hintzen, R. Q., Boven, L. A., 't Hart, B. A., Laman, J. D.
(2006). Phagocytes Containing a Disease-Promoting Toll-Like Receptor/Nod Ligand Are Present in the Brain during Demyelinating Disease in Primates. Am. J. Pathol.
169: 1671-1685
[Abstract]
[Full Text]
-
Nadesalingam, J., Dodds, A. W., Reid, K. B. M., Palaniyar, N.
(2005). Mannose-Binding Lectin Recognizes Peptidoglycan via the N-Acetyl Glucosamine Moiety, and Inhibits Ligand-Induced Proinflammatory Effect and Promotes Chemokine Production by Macrophages. J. Immunol.
175: 1785-1794
[Abstract]
[Full Text]
-
Visser, L., Jan de Heer, H., Boven, L. A., van Riel, D., van Meurs, M., Melief, M.-J., Zahringer, U., van Strijp, J., Lambrecht, B. N., Nieuwenhuis, E. E., Laman, J. D.
(2005). Proinflammatory Bacterial Peptidoglycan as a Cofactor for the Development of Central Nervous System Autoimmune Disease. J. Immunol.
174: 808-816
[Abstract]
[Full Text]
-
Raue, H.-P., Brien, J. D., Hammarlund, E., Slifka, M. K.
(2004). Activation of Virus-Specific CD8+ T Cells by Lipopolysaccharide-Induced IL-12 and IL-18. J. Immunol.
173: 6873-6881
[Abstract]
[Full Text]
-
Karlsson, H., Hessle, C., Rudin, A.
(2002). Innate Immune Responses of Human Neonatal Cells to Bacteria from the Normal Gastrointestinal Flora. Infect. Immun.
70: 6688-6696
[Abstract]
[Full Text]
-
Yang, S., Sugawara, S., Monodane, T., Nishijima, M., Adachi, Y., Akashi, S., Miyake, K., Hase, S., Takada, H.
(2001). Micrococcus luteus Teichuronic Acids Activate Human and Murine Monocytic Cells in a CD14- and Toll-Like Receptor 4-Dependent Manner. Infect. Immun.
69: 2025-2030
[Abstract]
[Full Text]
-
Nair, S. P., Williams, R. J., Henderson, B.
(2000). Advances in our understanding of the bone and joint pathology caused by Staphylococcus aureus infection. Rheumatology (Oxford)
39: 821-834
[Full Text]
-
Joosten, L. A B, Helsen, M. M A, van den Berg, W. B
(2000). Blockade of endogenous interleukin 12 results in suppression of murine streptococcal cell wall arthritis by enhancement of interleukin 10 and interleukin 1Ra. Ann Rheum Dis
59: 196-205
[Abstract]
[Full Text]